FT

Oxford/AstraZeneca study supports UK decision to delay second doses

Photo of Financial Times Financial Times
0 Less than a minute

New Oxford analysis, not yet peer-reviewed, shows single dose is 76% effective for up to 12 weeks

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

Bond trading surge sends Deutsche Bank to highest profit in 6 quarters

India pushed to expand Covid-19 vaccine drive as cases surge

Pelosi ‘optimistic’ about prospects for US stimulus deal

Hedge fund Elliott builds multibillion-pound stake in GSK

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button